Submitted by Anonymous (not verified) on 20 January 2026 - 16:36
Human medicines European public assessment report (EPAR): Ponlimsi, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ponlimsi, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised